Jack Y. Zhang - 10 Jun 2024 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
CEO & CHIEF SCIENTIFIC OFFICER, Director, 10%+ Owner
Signature
/s/ Eva Wen, by power of attorney for Jack Y. Zhang
Issuer symbol
AMPH
Transactions as of
10 Jun 2024
Transactions value $
$1,469,000
Form type
4
Filing time
11 Jun 2024, 18:35:15 UTC
Previous filing
19 Mar 2024
Next filing
16 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $1,469,000 +100,000 +4.11% $14.69* 2,533,554 10 Jun 2024 Direct
holding AMPH Common Stock 1,229,756 10 Jun 2024 See footnote F1
holding AMPH Common Stock 6,827,679 10 Jun 2024 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -100,000 -20.4% $0.000000 390,477 10 Jun 2024 Common Stock 100,000 $14.69 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife.
F2 The shares are held of record by Applied Physics and Chemistry Laboratories, Inc., of which the reporting persons and The Bill Luobei Zhang 2004 Irrevocable Trust are the sole owners.
F3 Shares subject to the option are fully vested and immediately exercisable.